Published in J Low Genit Tract Dis on January 01, 2016
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer (2002) 15.46
Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med (1998) 11.61
Improved amplification of genital human papillomaviruses. J Clin Microbiol (2000) 11.50
Papillomavirus infections--a major cause of human cancers. Biochim Biophys Acta (1996) 7.79
Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol (2003) 7.35
Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 6.01
2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol (2013) 5.40
Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol (1987) 5.00
Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol (1993) 4.67
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol (2012) 3.51
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis (2012) 3.19
Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol (2015) 3.10
Regression of low-grade squamous intra-epithelial lesions in young women. Lancet (2004) 2.98
Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol (2009) 2.74
Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis (2005) 2.51
Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol (1998) 2.37
Practice improvement in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women. J Low Genit Tract Dis (2010) 2.03
Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis (1995) 1.94
Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynecol (2010) 1.94
Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst (2003) 1.84
Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance. Cancer Epidemiol Biomarkers Prev (2011) 1.74
Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma. Cancer (2007) 1.30
Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women. Cancer Epidemiol Biomarkers Prev (2010) 1.21
Gene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer. Int J Cancer (2008) 1.21
Adolescent cervical dysplasia: histologic evaluation, treatment, and outcomes. Am J Obstet Gynecol (2007) 1.16
Risks for cervical intraepithelial neoplasia 3 among adolescents and young women with abnormal cytology. Obstet Gynecol (2008) 1.13
Persistence of genital human papillomavirus infection in a long-term follow-up study of female university students. J Infect Dis (2008) 1.09
Management of cervical intraepithelial neoplasia 2 in adolescent and young women. J Pediatr Adolesc Gynecol (2007) 0.98
Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers. Mol Diagn Ther (2007) 0.96
Screening for cervical cancer in the era of the HPV vaccine--the urgent need for both new screening guidelines and new biomarkers. J Natl Cancer Inst (2008) 0.92
Biomarkers in cervical precancer management: the new frontiers. Future Oncol (2008) 0.86
HPV prevalence at enrollment and baseline results from the Carolina Women's Care Study, a longitudinal study of HPV persistence in women of college age. Int J Womens Health (2013) 0.85
Disparity in the persistence of high-risk human papillomavirus genotypes between African American and European American women of college age. J Infect Dis (2014) 0.84
Delaying Pap test screening in the adolescent population: an evidence-based approach. J Pediatr Adolesc Gynecol (2013) 0.81
Practice Bulletin No. 140: management of abnormal cervical cancer screening test results and cervical cancer precursors. Obstet Gynecol (2013) 0.80
Cervical intraepithelial neoplasia in young women. J Obstet Gynaecol (2007) 0.77
Prognosis of intraepithelial cervical lesion during adolescence in up to two years of follow-up. J Pediatr Adolesc Gynecol (2010) 0.76
Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma. Nat Genet (2009) 2.58
Frequent mutations in the MITF pathway in melanoma. Pigment Cell Melanoma Res (2009) 2.27
RNA degradation in human breast tissue after surgical removal: a time-course study. Exp Mol Pathol (2004) 1.85
Birthweight is associated with DNA promoter methylation of the glucocorticoid receptor in human placenta. Epigenetics (2011) 1.47
In utero exposures, infant growth, and DNA methylation of repetitive elements and developmentally related genes in human placenta. Environ Health Perspect (2011) 1.43
Gene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer. Int J Cancer (2008) 1.21
Maternal cigarette smoking during pregnancy is associated with downregulation of miR-16, miR-21, and miR-146a in the placenta. Epigenetics (2010) 1.17
Cervical cancer disparities in South Carolina: an update of early detection, special programs, descriptive epidemiology, and emerging directions. J S C Med Assoc (2006) 0.96
NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression. J Virol (2004) 0.94
HPV prevalence at enrollment and baseline results from the Carolina Women's Care Study, a longitudinal study of HPV persistence in women of college age. Int J Womens Health (2013) 0.85
A healthy lifestyle index is associated with reduced risk of colorectal adenomatous polyps among non-users of non-steroidal anti-inflammatory drugs. J Prim Prev (2015) 0.85
The synthetic caged garcinia xanthone cluvenone induces cell stress and apoptosis and has immune modulatory activity. Mol Cancer Ther (2010) 0.84
Human retinoblastoma is not caused by known pRb-inactivating human DNA tumor viruses. Int J Cancer (2007) 0.84
TGF-β regulation of gene expression at early and late stages of HPV16-mediated transformation of human keratinocytes. Virology (2013) 0.83
Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation. Cancer Lett (2009) 0.82
Partial loss of Smad signaling during in vitro progression of HPV16-immortalized human keratinocytes. BMC Cancer (2013) 0.79
Role of micro-RNAs in regulation of lentiviral latency and persistence. Appl Immunohistochem Mol Morphol (2006) 0.79
Human Papillomavirus Type 16 L2 DNA Methylation in Exfoliated Cervical Cells From College-Age Women. J Low Genit Tract Dis (2016) 0.78
Ski protein levels increase during in vitro progression of HPV16-immortalized human keratinocytes and in cervical cancer. Virology (2013) 0.77
NFI is an essential positive transcription factor for human papillomavirus type 16 early gene expression. Open Virol J (2007) 0.76
HPV high risk and protective behaviors: the effects of religious affiliation. J Relig Health (2012) 0.75
Experiences of Discrimination and Incident Type 2 Diabetes Mellitus: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Epidemiol (2017) 0.75
Sedentary Behaviors and Cardiometabolic Risk, an Isotemporal Substitution Analysis. Am J Epidemiol (2017) 0.75
HSIL pap test and risk factors predicting acquisition of CIN 2/3 on colposcopy-directed biopsies. J S C Med Assoc (2009) 0.75